Targeting parasite's DNA can be more effective way to treat malaria: Study

London:Targeting a parasite’s DNA could be a more effective way to combat malaria, a disease that remains a major cause of death globally, according to new research.

According to the World Health Organization, there were 241 million clinical cases of malaria globally in 2020.

Malaria is a serious infection that is spread by mosquitoes. Although the disease is preventable and treatable, it remains a major cause of death globally - the estimated number of malaria deaths in 2020 stood at 627,000, the University of Sheffield has said.

The research team from the varsity’s Department of Infection, Immunity and Cardiovascular Disease examined and targeted an enzyme that maintains the classic double-helical structure of the parasite’s DNA, which contains the blueprint of life.

This solution works by targeting and inhibiting the parasite protein that de-branches forked DNA - an enzyme known as Flap Endonuclease - the team predicted the parasite would die quickly as its genome collapses. Using molecules that target the parasite enzyme, but not the human equivalent, could be a more effective way to treat the life-threatening disease.

“Most people haven’t heard of branched DNA, apart from maybe in The X Files Sci-Fi show when aliens implanted branched DNA into Agent Scully’s genome to track her movements,” said Jon Sayers, professor of Functional Genomics at the varsity, who is leading the project.

“In reality, branches in DNA occur frequently every time a cell divides. These branches have to be correctly trimmed, like a gardener might trim off suckers from a rose bush. Cells use Flap Endonucleases to do this job and we’ve exploited differences between the parasite and the human enzyme,” Sayers said.

The research programme was funded by a USD 1.2 million grant from the Bill & Melinda Gates Foundation in January 2022. This was built on an earlier award of USD 463,000 in 2019.

“Our intention is to use the additional funding to develop new drugs which will be even more effective in treating Malaria. To accelerate our research, we will be working in collaboration with scientists in the USA and China,” said Sayers.

“Of the estimated 627,000 people who died of malaria, most of them were children living in Africa. The disease disproportionately affects poorer nations, maintaining a vicious cycle of disease and poverty.” The interdisciplinary research team also included Dr Pat Baker and Professor Jon Waltho from the university.

“We’ve used the UK’s national synchrotron, the Diamond Light Source to study the malaria protein. The synchrotron works like a giant microscope, producing superbright X-rays that let us see the structure of the parasite enzyme,” said Baker, senior lecturer in Structural Biology.

“Magnetic resonance methods allow us to study how the parasite enzyme moves and folds around DNA branches, and we can use that information to make better drugs,” said Waltho, Gibson Chair in Biophysics.

The impact of the research is extremely important and timely as global warming increases the possible habitat for the mosquitoes which carry the parasite, exposing more people to future infection.